Parkinson’s Progression Markers Initiative (PPMI): Defining PD biology to accelerate PD therapeutics
Objective: The overall goal of PPMI is to identify, test and validate biomarkers of PD to accelerate therapeutic development throughout the PD continuum. Background: PPMI…Traveling through the telescope: a neuromuscular and a movement disorders reunion
Objective: We aim to raise awareness to an uncommon but possible combination of Parkinson Disease (PD) and Myasthenia Gravis (MG). Background: The co-occurrence of PD…Trends in the evaluation and management of constipation in patients with Parkinson disease
Objective: Explore common evaluation and management strategies for constipation in patients with Parkinson disease (PD) at a tertiary center. Background: PD is diagnosed based on…Optimizing DBS in PD: Investigating LFP beta power fluctuations in response to chronic stimulation
Objective: To determine if fluctuations in local field potential (LFP) beta power (BP) can be measured over time and whether the degree of fluctuation improves…Characterizing Hospital Admissions in Parkinson’s Disease: 10-Year Retrospective Study of Administrative Data in Alberta, Canada
Objective: Characterizing province-wide hospital admissions in persons with Parkinson’s disease (PD) to inform future healthcare improvement in this population. Background: Persons with PD have longer…Real-life heart rate assessment: a digital biomarker for autonomic dysfunction in early Parkinson’s disease?
Objective: To assess whether 1) tremor and dyskinesia affect photoplethysmography (PPG) data quality, and 2) heart rate (HR) analysis based on continuous PPG can be…Estrogen derivatives and hydrogen peroxide as promising biomarkers in parkinson’s disease-preliminary results
Objective: The study aimed to identify biomarkers of early-stage neurodegeneration in Parkinson’s disease (PD). Background: The currently available diagnostic clinical criteria for PD enable diagnosis…Stepwise Dual-Target MR-guided Focused Ultrasound in A Patient with Advanced Parkinson’s Disease
Objective: To illustrate a successful stepwise dual target MRI guided focused ultrasound ablation in a patient with advanced Parkinson's disease (PD). Background: MR-guided focused ultrasound…Widespread Synuclein pathology in hyposmics precedes dopamine transporter deficit in PARS
Objective: The Parkinson Associated Risk syndrome (PARS) study is designed to identify a Parkinson disease (PD) biomarker/clinical marker derived cohort enriched to develop typical symptoms…Development of an Item Bank for Assessing Psychosis in Parkinson’s Disease: A Systematic Review
Objective: This study aimed to develop an item bank for assessing psychosis in Parkinson's disease (PD). Background: Psychosis is a common and debilitating symptom in…
- « Previous Page
- 1
- …
- 203
- 204
- 205
- 206
- 207
- …
- 436
- Next Page »
